FDA to Regulate Some Homeopathic Products; CFI Hails Move


It’s finally happened. Homeopathic remedies are going to come under some regulatory oversight in the United States.

The U.S. Food and Drug Administration (FDA) announced on December 17 that it is taking a new, harder line on homeopathic products, targeting products that science and evidence indicate pose the greatest risk to Americans’ health and safety.

The Center for Inquiry (CFI), which had long been campaigning for regulation of homeopathic drugs, welcomed the move.

This article is available to subscribers only.
Subscribe now or log in to read this article.